Glypican-3 (GPC3), previously called MRX7, is a membrane-associated heparan sulfate proteoglycan that is up-regulated in hepatocellular carcinoma (HCC), especially in poorly-differentiated subsets, with absent or scarce expression in normal liver tissue (151, 152). This evidence concerns the gene CD44 and hepatocellular carcinoma.